ClinicalTrials.Veeva

Menu

We-INtervention Among Chinese HIV-serodiscordant Male Couples

C

City University of Hong Kong

Status

Enrolling

Conditions

HIV

Treatments

Behavioral: We-INtervention
Behavioral: Usual Care Group

Study type

Interventional

Funder types

Other

Identifiers

NCT06639932
We-INtervention

Details and patient eligibility

About

HIV-serodiscordant male couples, in which one male partner is HIV-seropositive and the other is HIV-seronegative, experience multiple risks in HIV care and prevention. As stigma often hinders such couples' access to support and services, leveraging their relational resources is crucial for optimizing their outcomes. The proposed study will assess the efficacy of the three-session We-INtervention focusing on their relationship dynamics to enhance Chinese HIV-serodiscordant male couples' health and well-being.

A total of 160 Chinese HIV-serodiscordant male couples (320 individuals: 160 HIV-seropositive and 160 HIV-seronegative) will be randomized at a 1:1 ratio to either the intervention or control arm. In the intervention arm, the We-INtervention will be delivered to both partners of each couple separately. In the control arm, each couple will receive health information pamphlets.

Full description

A pilot randomized controlled trial has already demonstrated the feasibility, acceptability, cultural sensitivity, and preliminary efficacy of the We-INtervention in improving the quality of life, psychological well-being, relationship satisfaction, and health behaviors of both partners in HIV-serodiscordant male couples. The proposed randomized controlled trial will extend the pilot study to examine the effects of the We-INtervention on stigma perception and other HIV-related behavioral outcomes, the mediators that account for the intervention effects, and the conditions under which the intervention is most effective.

The We-INtervention, if found to be effective, will be a valuable supplement to existing medical care modules.

Enrollment

320 estimated patients

Sex

Male

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. both partners are male,
  2. both partners are aged 18 or above,
  3. both partners report being in a committed relationship for at least 3 months,
  4. one partner is HIV-seropositive and the other partner is HIV-seronegative (i.e., serodiscordant couple),
  5. both partners have disclosed their serostatus to each other, and
  6. both partners are willing to participate in this study.

Exclusion criteria

  1. either partner is unable to complete the assessment due to a low education level or to physical or psychological constraints and
  2. either partner has been diagnosed with another chronic disease (e.g., cancer and coronary heart disease).

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

320 participants in 2 patient groups

We-INtervention group
Experimental group
Description:
The interventionists at each study site will be either healthcare providers (e.g., nurses), social workers, or psychologists with at least 3 years of experience serving HIV-serodiscordant male couples.
Treatment:
Behavioral: We-INtervention
Usual care group
Active Comparator group
Description:
The participants in the control condition will receive regular care.
Treatment:
Behavioral: Usual Care Group

Trial contacts and locations

4

Loading...

Central trial contact

Jianhua Hou, MS; Nancy Xiaonan Yu, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems